“I felt like I was dying, like something was killing me from the inside.”Another patient, mother-of-three Laura Linkson, said the coil left her “stuck in bed unable to move without pain, at some points being suicidal”. The implant is an option for those who cannot undergo key-hole surgery sterilisationCredit:Alamy The nickel and polyester coil is used to permanently sterilise women by aggravating the fallopian tubes so they are sealed by scar tissue, which then blocks eggs from reaching the womb.Known as hysteroscopic sterilisation, the procedure is used on women unable to undergo keyhole surgery.But it is feared some patients react badly to the nickel and plastic fibres.In other cases the device has perforated the fallopian tube and fallen out, embedding itself elsewhere in the body.Because of how the coils are attached, the only way to take them out is to remove the fallopian tubes, and often the uterus as well.Victoria Dethier, who received an Essure implant in 2012, told the Victoria Derbyshire programme: “There were moments where I couldn’t get out of bed I was in so much pain. I felt like something was killing me from the insideVictoria Dethier, patient However, senior obstetrician Ben Peyton-Jones, from Royal Devon and Exeter NHS Foundation Trust said Essure “has a place” for women unable to undergo keyhole surgery, providing the risks are carefully explained. Want the best of The Telegraph direct to your email and WhatsApp? Sign up to our free twice-daily Front Page newsletter and new audio briefings. Essure was awarded a CE Marking, certifying the device conforms to European Standards, by the National Standards Authority of Ireland, who yesterday said it was suspending certification for 90 days.This means no further devices may be sold, although those already in the supply chain may continue to be used.The manufacturer, Bayer, insists the product is safe, but has asked UK hospitals to temporarily refrain from using it during the period.The Medicines and Healthcare Products Regulatory Agency (MHRA) has the power to ban dangerous devices in the UK, but a spokesman said: “there is currently no evidence to suggest any increased risk to patient safety.”The organisation also refused to say how many reports of problems it had received, citing commercial confidentiality reasons.Carl Heneghan, an epidemiologist at the Centre for Evidence-based Medicine at Oxford University, criticised the MHRA’s lack of action, saying: “How much evidence to you need to say ‘let’s withdraw this from the market’?”The clinical trial that formed part of the evidence for the device being approved for use has also been criticised for not taking into account to the long-term effect of Essure on patients. Hospitals have been warned to stop using a metal implant to sterilise women after patients were left in agony and required hysterectomies to remove the devices.Recipients of the Essure implant have reported “suicidal” desperation and significant hair loss, as it emerged the product’s manufacturer has asked doctors to suspend its use.UK regulators have also faced criticism for failing to ban the device and refusing to reveal how many women have reported problems.